Contract logistics firm DHL Supply Chain said it will expand its U.S. pharmaceutical and medical device network by 40 percent this year, investing $150 million in new facilities, technology, and other enhancements, the company said today.
The Westerville, Ohio, firm said it plans to build nine new sites by the end of 2019, bringing its total number of sites devoted to compliant pharmaceutical and medical device distribution to 30 nationwide. The investment covers the cost of new buildings and technology, as well as the expansion of existing operations, the company said. Target markets include Indianapolis, Ind.; Raleigh, N.C.; and Memphis, Tenn., along with South Central Pennsylvania, California, and Virginia, the company also said.
The pharmaceutical and medical device distribution facilities are part of DHL Supply Chain's life sciences and healthcare business. The new and enhanced sites feature temperature-controlled space that supports pharmaceutical storage requirements, along with space for packaging and managed transportation services, the company said.
DHL Supply Chain is a business of logistics giant Deutsche Post DHL Group.